Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added to the page, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:09:29.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-03-07T12:47:11.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive changes to page content or study details were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:28:27.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T23:51:34.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and updates footer-related metadata, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T21:55:32.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page shows a new revision label (Revision: v3.3.4) replacing the previous (Revision: v3.3.3); this is a system-level update and does not affect the study details or how to participate. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:28:43.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.